NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

AAREY DRUGS & PHARMACEUTICALS LTD. (BSE: 524412)

 
524412 Technical Analysis
4
As on 24th Dec 2024 524412 SHARE Price closed @ 56.84 and we RECOMMEND Buy for LONG-TERM with Stoploss of 48.27 & Strong Buy for SHORT-TERM with Stoploss of 49.33 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

524412SHARE Price

Open 56.84 Change Price %
High 56.84 1 Day -1.16 -2.00
Low 56.84 1 Week 8.33 17.17
Close 56.84 1 Month 8.33 17.17
Volume 897 1 Year 12.44 28.02
52 Week High 68.00 | 52 Week Low 37.00
 
BSE INDIA Most Active Stocks
532822 7.47 -0.13%
532411 0.41 0.00%
517001 0.09 12.50%
511700 1.01 -0.98%
512149 0.88 0.00%
511389 7.25 -2.42%
534690 7.65 4.79%
532775 2.04 -0.97%
531328 1.05 0.96%
532648 19.80 -0.60%
 
BSE INDIA Top Gainers Stocks
519200 3.05 281.25%
512063 18.00 200.00%
530905 50.00 194.12%
513630 1.77 86.32%
512559 48.48 20.00%
530883 23.40 20.00%
521234 44.24 19.99%
590074 7.73 15.72%
507864 85.03 14.46%
526544 7.53 14.09%
 
BSE INDIA Top Losers Stocks
513012 0.68 -87.17%
504387 25.70 -76.38%
505658 2.99 -73.93%
509910 22.68 -68.32%
507543 2.58 -30.46%
533102 222.15 -19.99%
506113 134.40 -19.95%
533004 3.35 -18.29%
531838 0.05 -16.67%
533498 90.00 -15.61%
 
 
524412
Daily Charts
524412
Intraday Charts
Whats New @
Bazaartrend
524412
Free Analysis
 
524412 Important Levels Intraday
RESISTANCE56.84
RESISTANCE56.84
RESISTANCE56.84
RESISTANCE56.84
RESISTANCE56.84
RESISTANCE56.84
RESISTANCE56.84
RESISTANCE56.84
 
524412 Target June 2025
4th UP Target0
3rd UP Target0
2nd UP Target0
1st UP Target0
1st DOWN Target0
2nd DOWN Target0
3rd DOWN Target0
4th DOWN Target0
 
524412 Weekly Target
4th UP Target0.00
3rd UP Target0.00
2nd UP Target0.00
1st UP Target0.00
1st DOWN Target0.00
2nd DOWN Target0.00
3rd DOWN Target0.00
4th DOWN Target0.00
 
524412 Target2025
4th UP Target115.57
3rd UP Target94.71
2nd UP Target81.82
1st UP Target68.92
1st DOWN Target32.14
2nd DOWN Target19.24
3rd DOWN Target6.35
4th DOWN Target-14.51
 
 
524412 Other Details
Segment EQ
Market Capital 695694848.00
Sector Other
Industry Other
Offical website >
 
524412 Address
524412
 
524412 Latest News
 
Your Comments and Response on AAREY DRUGS & PHARMACEUTICALS LTD.
 
524412 Business Profile
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, bulk drugs, intermediates, and specialty chemicals for various industrial applications in India. The company offers mono methyl and dimethyl urea, theobromine, mefanamic acid, bromomethyl, and dioxolane. It also offers chemicals and solvents, which include aeromatics chemicals, chemical acids, chlor alkalies, glycols and glycol ethers, fiber intermediates, acetates and esters, and chlorinated solvents, as well as industrial alchols, ketones, amines, oleochemicals, intermediates, olefines, phosphates, fertilizers, monomers, and chemicals. The company's pharmaceutical products are used by pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. It also trades in industrial solvents and chemicals. The company was formerly known as Niharika Textiles & Chemicals Private Limited and changed its name to Aarey Drugs & Pharmaceuticals Limited in March 1993. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India. Address: 107, 204 Sahakar Bhavan, Mumbai, India, 400009
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service